Cat.#: ACPP-1352
| Despition | Myocilin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1298 | Syndecan-1 Blocking Peptide (AC1298) | 250 µg | inquiry |
| ACPP-1839 | Human Ornithine Aminotransferase Protein (AC1839) | 5 µg | inquiry |
| ACPP-1134 | Recombinant Mouse ROR1 Protein (6×His Tag) (AC1134) | 50 µg | inquiry |
| ACPP-1365 | Progesterone Receptor Blocking Peptide (AC1365) | 250 µg | inquiry |
| ACPP-1605 | Human PNMT Protein (AC1605) | 5 µg | inquiry |
| ACPP-1791 | Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1791) | 100 µg | inquiry |
| ACPP-1675 | Human TOR1A Protein (AC1675) | 5 µg | inquiry |
| ACPP-1152 | PAX5 Blocking Peptide (AC1152) | 250 µg | inquiry |
| ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
| ACPP-1169 | proBNP Blocking Peptide (AC1169) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.